Quantcast
Home > Quotes > CASI
CASI

CASI Pharmaceuticals, Inc. Common Stock (CASI) Quote & Summary Data

$7.63
*  
0.24
3.25%
Get CASI Alerts
*Delayed - data as of Aug. 17, 2018  -  Find a broker to begin trading CASI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
11
Today's High / Low
$ 7.76 / $ 7.34
Share Volume
170,728
50 Day Avg. Daily Volume
690,104
Previous Close
$ 7.39
52 Week High / Low
$ 8.8916 / $ 0.9269
Market Cap
657,288,624
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.4

Intraday Chart

Shares Traded

Share Volume:
170,728
50 Day Avg. Daily Volume:
690,104

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.23

Trading Range

The current last sale of $7.63 is 723.17% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 7.76 $ 8.8916
 Low: $ 7.34 $ 0.9269

Company Description (as filed with the SEC)

CASI Pharmaceuticals, Inc. ("CASI", the "Company") (Nasdaq: CASI) is a U.S. based biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients. We intend to execute our plan to become a leading pharmaceutical company with a substantial market share in China. We are headquartered in Rockville, Maryland with established China operations that are growing as we continue to further in-license or acquire products for our pipeline. Our product pipeline features (1) EVOMELA®, MARQIBO®, and ZEVALIN®, all U.S. Food and Drug Administration ("FDA") approved drugs in-licensed from Spectrum Pharmaceuticals, Inc.  ... More ...  


Risk Grade

Where does CASI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 7.35
Open Date:
Aug. 17, 2018
Close Price:
$ 7.63
Close Date:
Aug. 17, 2018

Consensus Recommendation

Analyst Info